Motor Neurone Disease Trial, Recruiting NCT02964637 Sponsor: University Health Network, Toronto Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT02964637
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must have a trusted person (such as a family member or close friend) who knows you well and can answer questions about how you are functioning day-to-day.
  • You must be able to read, understand, and speak English, as the memory and thinking tests are conducted in English.
  • You must have been diagnosed with one of the following conditions: a likely form of behavioral variant FTD, a scan-supported form of non-fluent variant PPA, a scan-supported form of semantic variant PPA (with a specific brain scan result), a likely form of Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP), or FTD with motor neuron disease (confirm with trial site for exact diagnosis details).
  • If you are joining as a healthy volunteer (control subject), you must have a normal neurological check-up, score 0 on a standard memory assessment scale, and score 28 or higher on a common thinking and memory test called the MMSE.

Who may not be able to join:

  • People whose symptoms, brain scans, or spinal fluid results suggest they may have Alzheimer's disease instead of the conditions listed above.
  • People who have a history of a serious head injury, brain tumour, stroke, or other brain or mental health conditions that could explain their symptoms.
  • Women who have not yet gone through menopause may be asked to take a pregnancy test before each scan, and pregnant women cannot take part because the PET scan could potentially be harmful to an unborn baby.
  • People who have a pacemaker, aneurysm clips, artificial heart valves, ear implants, or any metal fragments or foreign objects in their eyes, skin, or body.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria C Tartaglia, M.D., Toronto Western Hospital, UHN; Tanz CRND

Phone: 416-507-6880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2015
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Structural and Functional Diffferences between the FTLD groups via MRI of the brain; Differences between the FTLD groups via PET imaging of the brain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov